JP2012100676A5 - - Google Patents

Download PDF

Info

Publication number
JP2012100676A5
JP2012100676A5 JP2011290448A JP2011290448A JP2012100676A5 JP 2012100676 A5 JP2012100676 A5 JP 2012100676A5 JP 2011290448 A JP2011290448 A JP 2011290448A JP 2011290448 A JP2011290448 A JP 2011290448A JP 2012100676 A5 JP2012100676 A5 JP 2012100676A5
Authority
JP
Japan
Prior art keywords
antibody
cell
kit
endosialin
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011290448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012100676A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012100676A publication Critical patent/JP2012100676A/ja
Publication of JP2012100676A5 publication Critical patent/JP2012100676A5/ja
Pending legal-status Critical Current

Links

JP2011290448A 2005-04-22 2011-12-29 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体 Pending JP2012100676A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67434405P 2005-04-22 2005-04-22
US60/674,344 2005-04-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008508001A Division JP2008538700A (ja) 2005-04-22 2006-04-24 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体

Publications (2)

Publication Number Publication Date
JP2012100676A JP2012100676A (ja) 2012-05-31
JP2012100676A5 true JP2012100676A5 (https=) 2013-04-04

Family

ID=37215438

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008508001A Pending JP2008538700A (ja) 2005-04-22 2006-04-24 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体
JP2011290448A Pending JP2012100676A (ja) 2005-04-22 2011-12-29 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008508001A Pending JP2008538700A (ja) 2005-04-22 2006-04-24 免疫エフェクター活性を有するエンドシアリン細胞に内部移行する抗体

Country Status (6)

Country Link
US (3) US7615372B2 (https=)
EP (1) EP1871809A2 (https=)
JP (2) JP2008538700A (https=)
AU (1) AU2006241235B2 (https=)
CA (1) CA2607455A1 (https=)
WO (1) WO2006116451A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648511A1 (en) * 2003-07-29 2006-04-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with enhanced effector function
EP1819736B1 (en) * 2004-12-03 2010-08-04 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
EP1871809A2 (en) 2005-04-22 2008-01-02 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
CA2682726C (en) 2007-04-05 2017-05-09 Morphotek, Inc. Methods for inhibiting the binding of endosialin to ligands
EP2568044B1 (en) * 2008-09-29 2015-04-08 The Trustees of The University of Pennsylvania Tumor vascular marker-targeted vaccines
WO2010118203A2 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
JP2013543379A (ja) 2010-09-29 2013-12-05 モルフォテック, インコーポレイテッド 操作されたヒトエンドシアリン発現齧歯動物
NL2007179C2 (en) 2011-07-26 2013-01-29 Stichting Katholieke Universiteit Chitosan-based hydrogels containing enzyme alkaline phosphatase.
WO2014164544A1 (en) 2013-03-09 2014-10-09 Baylor College Of Medicine Vascular-targeted t-cell therapy
GB201702926D0 (en) * 2017-02-23 2017-04-12 Univ Birmingham Modulators
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5789650A (en) * 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5342757A (en) 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
EP0686260B1 (en) * 1993-02-05 2003-07-09 Epigen, Inc. Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
DE4335025A1 (de) * 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel
DE69535002T2 (de) 1994-03-08 2006-12-07 Memorial Sloan-Kettering Cancer Center Rekombinante humanisierte antikörper gegen fb5
DE19541844C1 (de) * 1995-11-09 1997-07-24 Gsf Forschungszentrum Umwelt Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung
US6146894A (en) * 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
WO2000013575A1 (en) 1998-09-09 2000-03-16 U.S. Army Institute Of Surgical Research Method for monitoring arterial oxygen saturation
US20040048254A1 (en) 2000-03-15 2004-03-11 Alexander Olek Diagnosis of diseases associated with tumor supressor genes and oncogenes
JP2004527210A (ja) 2000-08-02 2004-09-09 ザ ジョンズ ホプキンス ユニバーシティー 内皮細胞発現パターンの評価法
WO2002054856A1 (en) 2001-01-15 2002-07-18 Morphotek Inc. Chemical inhibitors of mismatch repair
US20040043928A1 (en) 2001-08-02 2004-03-04 Ramesh Kekuda Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030124579A1 (en) 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20040014058A1 (en) 2001-10-05 2004-01-22 Alsobrook John P. Novel human proteins, polynucleotides encoding them and methods of using the same
EP2236614A3 (en) 2002-08-15 2011-01-26 Genzyme Corporation Brain endothelial cell expression patterns
US20040253606A1 (en) 2002-11-26 2004-12-16 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
EP2264073A1 (en) 2003-03-04 2010-12-22 Kirin Beer Kabushiki Kaisha Endothelial cell specific antibodies and uses thereof
US6905082B1 (en) * 2003-12-05 2005-06-14 Sheng Li Wu Sprayer device having buffering structure
WO2005086713A2 (en) 2004-03-04 2005-09-22 Kirin Brewery Co., Ltd. Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
WO2006017759A2 (en) 2004-08-05 2006-02-16 Kirin Brewery Co., Ltd. Tumor endothelial marker-1 (tem1) binding antibodies and uses thereof
WO2006029045A2 (en) 2004-09-03 2006-03-16 Kirin Brewery Co., Ltd. Endothelial cell specific antibodies and uses thereof
US20070292354A1 (en) 2004-09-23 2007-12-20 Guerbet Contrast Agents Encapsulating Systems for Cest Imaging
EP1819736B1 (en) * 2004-12-03 2010-08-04 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
CN101175862A (zh) 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法
EP1871809A2 (en) 2005-04-22 2008-01-02 Morphotek, Inc. Antibodies with immune effector activity and that internalize in endosialin-positive cells
DE102005050933A1 (de) 2005-10-21 2007-04-26 Justus-Liebig-Universität Giessen Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen
US7908090B2 (en) 2005-11-30 2011-03-15 The Board Of Trustees Of The Leland Stanford Junior University Signatures for human aging
EP1960552A2 (en) 2005-12-16 2008-08-27 Genentech, Inc. Method for diagnosing, prognosing and treating glioma
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
WO2008006517A2 (en) 2006-07-13 2008-01-17 Siemens Healthcare Diagnostics Gmbh Prediction of breast cancer response to taxane-based chemotherapy
EP2049713A4 (en) 2006-07-21 2010-06-16 Univ Alberta tissue rejection
EP2543739B1 (en) 2006-08-11 2015-07-22 Johns Hopkins University Consensus coding sequences of human colorectal cancers
US20080300170A1 (en) 2006-09-01 2008-12-04 Cohava Gelber Compositions and methods for diagnosis and treatment for type 2 diabetes
WO2008063479A2 (en) 2006-11-17 2008-05-29 Fred Hutchinson Cancer Research Center Pancreatic cancer biomarkers
US20110119776A1 (en) 2007-02-05 2011-05-19 Wong Kwok-Kin Methods of diagnosing and prognosing lung cancer
WO2008101118A2 (en) 2007-02-14 2008-08-21 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates
EP1986010A1 (en) 2007-04-05 2008-10-29 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Methods and tools for discriminating colorectal adenomas and adenocarcinomas
CA2682726C (en) 2007-04-05 2017-05-09 Morphotek, Inc. Methods for inhibiting the binding of endosialin to ligands
CA2733672C (en) 2007-08-16 2018-09-11 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
KR101810799B1 (ko) 2008-02-01 2017-12-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
CA2715774A1 (en) 2008-02-19 2009-08-27 Oncomethylome Sciences Sa Detection and prognosis of lung cancer
WO2009120877A2 (en) 2008-03-26 2009-10-01 The Johns Hopkins University Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases
US20100136584A1 (en) 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
WO2010033913A1 (en) 2008-09-22 2010-03-25 Icb International, Inc. Antibodies, analogs and uses thereof
US20110256560A1 (en) 2008-10-20 2011-10-20 University Health Network Methods and compositions for the detection of ovarian cancer
CA2749601C (en) 2009-01-14 2020-07-21 Stephen M. Hewitt Ratio based biomarkers and methods of use thereof
WO2010118203A2 (en) 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules

Similar Documents

Publication Publication Date Title
JP2012100675A5 (https=)
JP2012100676A5 (https=)
US20230355728A1 (en) Peptidic chimeric antigen receptor t cell switches and uses thereof
TWI853077B (zh) 新型抗cd39抗體
US12453770B2 (en) CLEC9A binding agents
US20240392002A1 (en) Anti-ror antibody constructs
US20220002418A1 (en) Anti-pd-l1/vegf bifunctional antibody and use thereof
JP2009521206A5 (https=)
US10138297B2 (en) Antibody neutralizers of human granulocyte macrophage colony stimulating factor
ES2688941T3 (es) Antagonistas del receptor 1 del factor de necrosis tumoral para tratar enfermedades respiratorias
RU2451689C2 (ru) Новые антипролиферативные антитела
JP2016509582A5 (https=)
WO2015032906A4 (en) Cd70-binding peptides and method, process and use relating thereto
WO2018050039A1 (zh) 新的抗pd-1纳米抗体及其应用
JP2017526339A5 (https=)
HRP20170254T1 (hr) Humanizirana i kimerna monoklonska protutijela usmjerena na cd47
JP2010526028A5 (https=)
CN109485729A (zh) Bcma和cd3的结合分子
EP3178847B1 (en) Anti-tnf-alpha fully human monoclonal antibodies with low immunogenicity and application thereof
JP2026021462A (ja) 抗tslpナノ抗体およびその使用
DE102011118022A1 (de) Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung
SA518400327B1 (ar) أجسام مضادة لبيتا انتيرفيرون واستخداماتها
JP2009521956A5 (https=)
JP2014500862A5 (https=)
CN113461825B (zh) 一种抗pd-l2纳米抗体及其应用